Centenarians are rare. In the United States, there are roughly 100,000 people over the age of 100. Supercentenarians, those who reach 110, number only in the hundreds worldwide.
What makes them different isn't luck. It isn't genetics alone. And it isn't simply the absence of disease.
It's their immune systems.
A review published in Nature Reviews Immunology in April 2026 examined what centenarians and supercentenarians have in common at the immunological level, drawing on decades of research across populations in Italy, Japan, Spain, China, and the United States. The findings are striking. And for anyone who has been paying attention to immune health research over the past few years, they're not entirely surprising.
What centenarians have that most people lose
The immune system ages. That's not a controversial statement. By the time most people reach their 60s and 70s, their immune function has changed significantly. Less precise, less adaptable, more prone to the chronic low-grade inflammation that researchers now call inflammaging. It's one of the most well-documented biological processes in human aging.
What's remarkable about centenarians isn't that they escaped this process entirely. It's that they managed it differently.
The Nature Reviews Immunology review describes centenarians as a biologically distinct population. Despite their advanced age, many show relatively preserved immune function and resistance to the conditions most people associate with growing old. This is especially pronounced in supercentenarians, whose immune profiles often resemble those of people decades younger.
The immune system of someone who lives past 100, it turns out, tends to maintain a kind of balance that most people's immune systems lose somewhere along the way. Not just the capacity to fight. The capacity to regulate.
The T-cell connection
Here's where the research gets specific, and where it connects directly to what Humanset has been built around for 35 years.
Studies across multiple populations have found that centenarians tend to maintain higher levels of functional T-cells than their shorter-lived peers. Crucially, these aren't just any T-cells. Research from Japan found that supercentenarians carry elevated levels of a specific subset of CD4+ T-cells, and that this same subset was found in people who lived well past 100 across different studies and different countries. It wasn't a coincidence. It was a pattern.
CD4+ T-cells are the coordinators of the immune response. They signal other immune cells to activate, help regulate the strength of the response, and play a central role in immune memory, the immune system's ability to recognize and respond appropriately to threats it has encountered before. Without them functioning well, the downstream immune response degrades.
This is precisely why thymic involution matters so much. The thymus is the organ responsible for maturing T-cell precursors into functional CD4+ T-cells. As the thymus shrinks with age, the supply of new, functional T-cells diminishes. The immune system increasingly relies on older, less adaptable cells. Coordination breaks down. The balance between response and regulation becomes harder to maintain.
What centenarians appear to have done, at least in part, is preserve more of that coordination. Not perfectly. Not indefinitely. But enough to make a measurable difference in how their immune systems function across an extraordinarily long life.
Immune balance, not just immune strength
This is worth slowing down on, because it runs counter to how most people think about immune health.
When most people think about a strong immune system, they picture one that fights hard. One that responds aggressively to threats. But the research on centenarians tells a more nuanced story. The immune systems that hold up over the longest lives aren't necessarily the most aggressive. They're the most balanced.
The Nature Reviews Immunology review notes that centenarians show evidence of limiting the damaging effects of inflammaging, including maintaining more appropriate inflammatory responses rather than the chronic, low-grade immune activation that accumulates in most people as they age. Their immune systems appear to retain the ability to respond when needed and stand down when not.
That capacity for balance isn't something that just happens. It depends on the regulatory T-cells that help keep the immune system from overreacting. It depends on immune memory that can distinguish real threats from background noise. And it depends, upstream of all of it, on a T-cell maturation process that continues to produce functional cells capable of doing those jobs.
That's the process TPA supports.
What this doesn't mean
We want to be direct about something.
Humanset is not claiming that TPA makes people live to 100. We are not saying that supplementing TPA produces the immune profile of a centenarian. That is not what this research shows, and that is not what we would ever claim.
What the research shows is that the immune systems of people who achieve exceptional longevity share specific characteristics, characteristics built around the kind of T-cell function and immune regulation that depends on healthy CD4+ activity. And TPA is the specific molecule responsible for maturing the T-cell precursors that make that CD4+ activity possible.
These are not the same claim. But they are connected. The biology that centenarian research keeps pointing back to, balanced immune function, preserved T-cell activity, regulated inflammatory response, is the same biology TPA was designed to support.
A pattern the science keeps confirming
The centenarian research joins a growing body of evidence that all points in the same direction.
The 2026 Nature thymus studies found that adults with healthier thymuses live longer and have lower rates of major disease. The 2023 New England Journal of Medicine study found that losing the thymus accelerates mortality. The Duke cancer vaccine research found that CD4+ T-cells are more essential to durable immune memory than the field previously understood. And now, research into the immune systems of people who live past 100 finds that preserved T-cell function and immune regulation are among the defining characteristics of exceptional longevity.
Each of these research threads comes from a different direction. They involve different patient populations, different methodologies, different research teams. And they keep arriving at the same place.
The immune system's capacity for balance, and the T-cell machinery that makes that balance possible, matters more than almost anything else when it comes to how well the body ages.
That has been the premise of Humanset's science for 35 years. The research is catching up.
To understand how TPA supports T-cell maturation, read How TPA Works. For the published research behind the science, visit The Science.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
